Lulu C. Bravo, MD
  • To give socialized training for all personnel (doctors, nurses and healthcare workers) involved in vaccination programmes.
  • To have adequate services regarding: accessibility of vaccine supplies, particularly of vaccine itself, vaccine record cards and registration materials and vaccine information sheets.
  • To provide a venue for research regarding the new emerging vaccines, its efficacy, surveillance, compliance and adverse reactions.
  • To facilitate discussions regarding problems as well as updates on the current vaccination status in the country.
  • To coordinate with other concerned agencies regarding its information education dissemination.
Ongoing Projects: 
  • Community and Hospital Burden of Norovirus Disease in Children.
  • Phase III, Double-Blind, Randomized, Placebo-Controlled Trial to Investigate the Efficacy, Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TDV) Administered Subcutaneously in Healthy Children Aged 4-16 Years Old.
  • Efficacy and Immunogenicity Study of Quadrivalent Influenza Vaccine Administered via the Intramuscular Route in Healthy Children Aged 6 to 35 Months.
  • Immunogenicity and Safety of Tetravalent Dengue Vaccine Given in 1-, 2-, or 3- Dose Schedules (STAGE I) Followed by a Single Booster Injection of the Same Vaccine (STAGE II) 1 or 2 Years after the Last Primary Dose in Healthy Subjects 9 to 50 Years of Age in Colombia and Philippines.